Literature DB >> 7395848

Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans County, Georgia.

D C Deubner, W E Wilkinson, M J Helms, H A Tyroler, C G Hames.   

Abstract

Linear logistic analysis of the relationship of cardiovascular disease risk factors to an overall measure of health effect, ten-year mortality, revealed significant associations of death with systolic blood pressure, age, sex, diabetes mellitus, smoking, cholesterol, obesity (Quetelet index), race and social index. Attributable risk and population attributable risk estimates were derived from the model by changing actual variable values to target values. The results confirmed systolic hypertension and smoking as major public health problems and diabetes mellitus as a powerful risk factor for death. The small detrimental effect of cholesterol on probability of death limits the potential for an overall beneficial effect of preventive intervention. In fact, drug intervention in two reported trials of cholesterol reduction had negative overall effects. Demonstration of the association of a characteristic with a specific disease state does not alone justify attempts to eliminate the high risk state from a population. An overall detrimental health effect must be documented by suitable studies before trials of preventive intervention are undertaken or recommendations made to the public.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7395848     DOI: 10.1093/oxfordjournals.aje.a112963

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  The prevalence of hypertension in seven populations of west African origin.

Authors:  R Cooper; C Rotimi; S Ataman; D McGee; B Osotimehin; S Kadiri; W Muna; S Kingue; H Fraser; T Forrester; F Bennett; R Wilks
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

2.  From exposures to population interventions: pregnancy and response to HIV therapy.

Authors:  Daniel Westreich
Journal:  Am J Epidemiol       Date:  2014-02-25       Impact factor: 4.897

3.  Model-based estimation of the attributable fraction for cross-sectional, case-control and cohort studies using the R package AF.

Authors:  Elisabeth Dahlqwist; Johan Zetterqvist; Yudi Pawitan; Arvid Sjölander
Journal:  Eur J Epidemiol       Date:  2016-03-18       Impact factor: 8.082

4.  Sample size and power based on the population attributable fraction.

Authors:  W S Browner; T B Newman
Journal:  Am J Public Health       Date:  1989-09       Impact factor: 9.308

5.  Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18-64.

Authors:  R D Ampon; M Williamson; P K Correll; G B Marks
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

6.  Avoidable hospitalizations and socio-economic status in Galveston County, Texas.

Authors:  C E Begley; C H Slater; M J Engel; T F Reynolds
Journal:  J Community Health       Date:  1994-10

7.  The effect of gender on the probability of myocardial infarction among emergency department patients with acute chest pain: a report from the Multicenter Chest Pain Study Group.

Authors:  M A Cunningham; T H Lee; E F Cook; D A Brand; G W Rouan; M C Weisberg; L Goldman
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

Review 8.  Systolic hypertension in the elderly.

Authors:  G H Rutan
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 9.  A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?

Authors:  R Zoratti
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

10.  Contrast in cardiac anatomy and function between black and white patients with hypertension.

Authors:  I W Hammond; M H Alderman; R B Devereux; E M Lutas; J H Laragh
Journal:  J Natl Med Assoc       Date:  1984-03       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.